Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Universal Vision Biotechnology Co., Ltd. (3218) Financial Statements

Universal Vision Biotechnology Co., Ltd. Financial Overview

Universal Vision Biotechnology Co., Ltd.'s market cap is currently NT$10.68B. The company's EPS TTM is NT$13.51; its P/E ratio is 9.40; and it has a dividend yield of 6.15%. Universal Vision Biotechnology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 4.20BNT$ 4.23BNT$ 4.08BNT$ 3.49BNT$ 2.63B
Gross ProfitNT$ 2.48BNT$ 2.53BNT$ 2.45BNT$ 2.14BNT$ 1.64B
Operating IncomeNT$ 1.38BNT$ 1.40BNT$ 1.31BNT$ 1.11BNT$ 776.59M
EBITDANT$ 1.92BNT$ 1.86BNT$ 1.78BNT$ 1.48BNT$ 1.10B
Net IncomeNT$ 1.04BNT$ 1.06BNT$ 1.05BNT$ 850.53MNT$ 595.43M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.10BNT$ 1.92BNT$ 1.64BNT$ 1.28BNT$ 1.04B
Total AssetsNT$ 6.09BNT$ 5.76BNT$ 5.13BNT$ 4.51BNT$ 3.75B
Total DebtNT$ 1.06BNT$ 1.05BNT$ 778.26MNT$ 783.65MNT$ 767.53M
Net DebtNT$ 284.10MNT$ 547.38MNT$ -284.28MNT$ 80.63MNT$ 233.34M
Total LiabilitiesNT$ 1.93BNT$ 2.01BNT$ 1.79BNT$ 1.68BNT$ 1.42B
Stockholders' EquityNT$ 4.02BNT$ 3.62BNT$ 3.18BNT$ 2.66BNT$ 2.19B
Cash Flow
Free Cash FlowNT$ 1.10BNT$ 1.23BNT$ 1.08BNT$ 775.34MNT$ 583.07M
Operating Cash FlowNT$ 1.67BNT$ 1.67BNT$ 1.55BNT$ 1.27BNT$ 911.77M
Investing Cash FlowNT$ -551.09MNT$ -1.48BNT$ -476.95MNT$ -564.65MNT$ -379.81M
Financing Cash FlowNT$ -837.73MNT$ -763.04MNT$ -710.65MNT$ -539.83MNT$ -612.33M

Currency in TWD

Universal Vision Biotechnology Co., Ltd. Earnings and Revenue History

01.5B3B4.5B16 %20 %24 %28 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Universal Vision Biotechnology Co., Ltd. Liabilities to Assets

02.5B5B7.5B30 %33 %36 %39 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Universal Vision Biotechnology Co., Ltd. Cash Flow

-2B-1B01B2B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Universal Vision Biotechnology Co., Ltd. Forecast EPS vs Actual EPS

012345Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >